Evaluating the Integration of Genomics into Cancer Screening Programmes: Challenges and Opportunities.

IF 1.4 Q4 GENETICS & HEREDITY
Current genetic medicine reports Pub Date : 2019-01-01 Epub Date: 2019-05-18 DOI:10.1007/s40142-019-00162-x
Sarah Briggs, Ingrid Slade
{"title":"Evaluating the Integration of Genomics into Cancer Screening Programmes: Challenges and Opportunities.","authors":"Sarah Briggs, Ingrid Slade","doi":"10.1007/s40142-019-00162-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>As the costs of genomic testing have fallen, and our understanding of genetic susceptibility to cancers has grown, there has been increasing interest in incorporating testing for cancer susceptibility genes, and polygenic risk estimates, into population cancer screening. A growing body of evidence suggests that this would be both clinically and cost-effective. In this article, we aim to explore the frameworks used to evaluate screening programmes, evaluate whether population screening for cancer susceptibility can be assessed using these standards, and consider additional issues and outcomes of importance in this context.</p><p><strong>Recent findings: </strong>There are tensions between traditional approaches of genetic testing (utilising tests with high sensitivity and specificity) and the principles of population screening (in which the screening test typically has low specificity), as well as the frameworks used to evaluate the two. Despite the existence of many screening guidelines, including consensus papers, these often do not align fully with broader considerations of genetic test evaluation. Population screening for genetic risk in cancer shifts the focus from diagnostics to prognostication and has wider implications for personal and familial health than existing screening programmes. In addition, understanding of the prevalence and penetrance of cancer susceptibility genes, required by many screening guidelines, may only be obtainable through population-level testing; prospective multi-disciplinary research alongside implementation will be essential.</p><p><strong>Summary: </strong>Appropriate evaluation of genetic screening for cancer risk will require modification of existing screening frameworks to incorporate additional complexity of outcomes and population values. As evidence supporting population screening for cancer susceptibility mounts, development of an appropriate evaluative framework, and expansion of public dialogue will be key to informing policy.</p>","PeriodicalId":72731,"journal":{"name":"Current genetic medicine reports","volume":"7 2","pages":"63-74"},"PeriodicalIF":1.4000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019642/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current genetic medicine reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40142-019-00162-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/5/18 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of review: As the costs of genomic testing have fallen, and our understanding of genetic susceptibility to cancers has grown, there has been increasing interest in incorporating testing for cancer susceptibility genes, and polygenic risk estimates, into population cancer screening. A growing body of evidence suggests that this would be both clinically and cost-effective. In this article, we aim to explore the frameworks used to evaluate screening programmes, evaluate whether population screening for cancer susceptibility can be assessed using these standards, and consider additional issues and outcomes of importance in this context.

Recent findings: There are tensions between traditional approaches of genetic testing (utilising tests with high sensitivity and specificity) and the principles of population screening (in which the screening test typically has low specificity), as well as the frameworks used to evaluate the two. Despite the existence of many screening guidelines, including consensus papers, these often do not align fully with broader considerations of genetic test evaluation. Population screening for genetic risk in cancer shifts the focus from diagnostics to prognostication and has wider implications for personal and familial health than existing screening programmes. In addition, understanding of the prevalence and penetrance of cancer susceptibility genes, required by many screening guidelines, may only be obtainable through population-level testing; prospective multi-disciplinary research alongside implementation will be essential.

Summary: Appropriate evaluation of genetic screening for cancer risk will require modification of existing screening frameworks to incorporate additional complexity of outcomes and population values. As evidence supporting population screening for cancer susceptibility mounts, development of an appropriate evaluative framework, and expansion of public dialogue will be key to informing policy.

评估将基因组学纳入癌症筛查计划的情况:挑战与机遇。
综述的目的:随着基因组检测成本的降低,以及我们对癌症遗传易感性认识的加深,将癌症易感基因检测和多基因风险估计纳入人群癌症筛查的兴趣日益浓厚。越来越多的证据表明,这样做既符合临床需要,又具有成本效益。本文旨在探讨用于评估筛查计划的框架,评估是否可以使用这些标准来评估癌症易感性人群筛查,并考虑在此背景下的其他重要问题和结果:基因检测的传统方法(利用灵敏度和特异性较高的检测方法)与人群筛查的原则(筛查检测的特异性通常较低)以及用于评估两者的框架之间存在矛盾。尽管有许多筛查指南,包括共识文件,但这些指南往往与基因检测评估的更广泛考虑并不完全一致。与现有的筛查计划相比,癌症遗传风险人群筛查将重点从诊断转移到预后,并对个人和家庭健康产生更广泛的影响。此外,许多筛查指南都要求了解癌症易感基因的流行率和渗透率,而这可能只有通过人群水平的测试才能获得;在实施过程中,前瞻性的多学科研究将是必不可少的。随着支持癌症易感性人群筛查的证据越来越多,制定适当的评估框架和扩大公众对话将是为政策提供信息的关键。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信